Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Marr Bio-Pharmaceutical is a specialized medical diagnostics company based in Beijing, China, focusing on the development and production of rapid testing solutions for infectious diseases. The company is most recognized for its "aware爱卫" brand, which features the first oral fluid-based HIV-1/2 antibody rapid test kit to receive approval from the China National Medical Products Administration (NMPA). Established in 2005, Beijing Marr operates an ISO 13485-certified manufacturing facility and provides non-invasive diagnostic tools widely used by public health organizations, medical institutions, and for home testing. In addition to its core diagnostic portfolio, the company offers OEM and ODM services for medical equipment and has expanded its reach into international markets. Beijing Marr is listed on the National Equities Exchange and Quotations (NEEQ) in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Marr Bio-Pharmaceutical.